3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
77
Myelodysplastic Syndromes
20
Leukemia, Myelomonocytic, Chronic
11
Myeloproliferative Disorders
6
Hematologic Neoplasms
5
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Neoplasms
3
Myelodysplastic-Myeloproliferative Diseases
3
Leukemia
3
Hematologic Diseases
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
GATA2 Deficiency
2
Sarcoma, Myeloid
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pathologic Complete Response
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Interventions
cabozantinib
5
Nivolumab
4
Ipilimumab
4
Axitinib
4
pembrolizumab
3
Blood Specimen Collection
3
zimberelimab
2
atezolizumab
2
Surveys and Questionnaires
2
Sunitinib
2
Irinotecan
2
temsirolimus
1
spartalizumab
1
salicylhydroxamic acid
1
palbociclib
1
orellanine
1
olaparib
1
liposomal doxorubicin
1
lenvatinib
1
gallium Ga 68 dotatate
1
fludarabine
1
brodalumab
1
belzutifan
1
aldesleukin
1
adagrasib
1
X-Rays
1
Vincristine
1
Temozolomide
1
Technetium Tc 99m Sestamibi
1
Taxes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Azacitidine
×
90 days
×
Clear all
No trials found.